Moment analysis for the separation of mean in vivo disintegration, dissolution, absorption, and disposition time of ampicillin products

Yusuke Tanigawara, K. Yamaoka, T. Nakagawa, T. Uno

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

The in vivo disintegration, dissolution, absorption, and disposition processes of ampicillin products are separated by means of moment analysis. This method is model-independent, that is, any specific model is not assumed. The mean residence time (MRT), mean absorption time (MAT), mean dissolution time (MDT), and mean disintegration time (MDIT) are calculated for several dosage forms of ampicillin. The fraction of dose absorbed (F) is also separated into several fractions corresponding to these in vivo processes. Bioavailability and bioequivalence are discussed in terms of the zero and first moments. The flip-flop behavior of ampicillin is proved by the fact that the MRT following intravenous injection is less than the MAT of any oral dosage form. Absorption of released ampicillin is proved to be a rate-determining step, since the MRT of released ampicillin in the GI tract is the greatest of all MRT corresponding to the in vivo processes. Moment analysis is compared with classical compartment theory, and a new component concept is introduced.

Original languageEnglish
Pages (from-to)1129-1133
Number of pages5
JournalJournal of Pharmaceutical Sciences
Volume71
Issue number10
Publication statusPublished - 1982
Externally publishedYes

Fingerprint

Disintegration
Ampicillin
Dissolution
Dosage Forms
Flip flop circuits
Therapeutic Equivalency
Intravenous Injections
Biological Availability
Gastrointestinal Tract

ASJC Scopus subject areas

  • Molecular Medicine
  • Chemistry(all)
  • Organic Chemistry
  • Drug Discovery
  • Pharmaceutical Science
  • Pharmacology

Cite this

Moment analysis for the separation of mean in vivo disintegration, dissolution, absorption, and disposition time of ampicillin products. / Tanigawara, Yusuke; Yamaoka, K.; Nakagawa, T.; Uno, T.

In: Journal of Pharmaceutical Sciences, Vol. 71, No. 10, 1982, p. 1129-1133.

Research output: Contribution to journalArticle

@article{bc7c534bf172436a934f168da79741c9,
title = "Moment analysis for the separation of mean in vivo disintegration, dissolution, absorption, and disposition time of ampicillin products",
abstract = "The in vivo disintegration, dissolution, absorption, and disposition processes of ampicillin products are separated by means of moment analysis. This method is model-independent, that is, any specific model is not assumed. The mean residence time (MRT), mean absorption time (MAT), mean dissolution time (MDT), and mean disintegration time (MDIT) are calculated for several dosage forms of ampicillin. The fraction of dose absorbed (F) is also separated into several fractions corresponding to these in vivo processes. Bioavailability and bioequivalence are discussed in terms of the zero and first moments. The flip-flop behavior of ampicillin is proved by the fact that the MRT following intravenous injection is less than the MAT of any oral dosage form. Absorption of released ampicillin is proved to be a rate-determining step, since the MRT of released ampicillin in the GI tract is the greatest of all MRT corresponding to the in vivo processes. Moment analysis is compared with classical compartment theory, and a new component concept is introduced.",
author = "Yusuke Tanigawara and K. Yamaoka and T. Nakagawa and T. Uno",
year = "1982",
language = "English",
volume = "71",
pages = "1129--1133",
journal = "Journal of Pharmaceutical Sciences",
issn = "0022-3549",
publisher = "John Wiley and Sons Inc.",
number = "10",

}

TY - JOUR

T1 - Moment analysis for the separation of mean in vivo disintegration, dissolution, absorption, and disposition time of ampicillin products

AU - Tanigawara, Yusuke

AU - Yamaoka, K.

AU - Nakagawa, T.

AU - Uno, T.

PY - 1982

Y1 - 1982

N2 - The in vivo disintegration, dissolution, absorption, and disposition processes of ampicillin products are separated by means of moment analysis. This method is model-independent, that is, any specific model is not assumed. The mean residence time (MRT), mean absorption time (MAT), mean dissolution time (MDT), and mean disintegration time (MDIT) are calculated for several dosage forms of ampicillin. The fraction of dose absorbed (F) is also separated into several fractions corresponding to these in vivo processes. Bioavailability and bioequivalence are discussed in terms of the zero and first moments. The flip-flop behavior of ampicillin is proved by the fact that the MRT following intravenous injection is less than the MAT of any oral dosage form. Absorption of released ampicillin is proved to be a rate-determining step, since the MRT of released ampicillin in the GI tract is the greatest of all MRT corresponding to the in vivo processes. Moment analysis is compared with classical compartment theory, and a new component concept is introduced.

AB - The in vivo disintegration, dissolution, absorption, and disposition processes of ampicillin products are separated by means of moment analysis. This method is model-independent, that is, any specific model is not assumed. The mean residence time (MRT), mean absorption time (MAT), mean dissolution time (MDT), and mean disintegration time (MDIT) are calculated for several dosage forms of ampicillin. The fraction of dose absorbed (F) is also separated into several fractions corresponding to these in vivo processes. Bioavailability and bioequivalence are discussed in terms of the zero and first moments. The flip-flop behavior of ampicillin is proved by the fact that the MRT following intravenous injection is less than the MAT of any oral dosage form. Absorption of released ampicillin is proved to be a rate-determining step, since the MRT of released ampicillin in the GI tract is the greatest of all MRT corresponding to the in vivo processes. Moment analysis is compared with classical compartment theory, and a new component concept is introduced.

UR - http://www.scopus.com/inward/record.url?scp=0019951604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019951604&partnerID=8YFLogxK

M3 - Article

C2 - 7143211

AN - SCOPUS:0019951604

VL - 71

SP - 1129

EP - 1133

JO - Journal of Pharmaceutical Sciences

JF - Journal of Pharmaceutical Sciences

SN - 0022-3549

IS - 10

ER -